skip to main content

Updated Visitor Guidelines

MENU

Patients + Families
Healthcare Professionals
Research + Education
Find a Doctor
News
Events
Maps + Directions
Locations
CANCER ANSWERLINE
Giving
About Us
U-M Patient Log-In
UofMHealth.org
Jobs
U-M Medical School
Rogel INTRANET

Patients + Families
Healthcare Professionals
Research + Education

A Phase I, open-label, dose escalation study of oral LGK974 in patients with malignancies dependent on Wnt ligands

The content on this page has moved. You can view it on this page.

Back to top

Find a Doctor

Enter the last name of the Doctor:

>Browse a list of all our doctors

For Patients + Families

Cancer Types/Programs
Find a Clinical Trial
Cancer AnswerLine: 800-865-1125

For Healthcare Professionals

Refer a Patient
Continuing Medical Education
News & Events
Refer a Patient: 800-962-3555

Research + Education

Research Programs
Education

Make a Donation

Give NOW
Fundraising Events
About Us
Jobs

Address + Info

U-M Rogel Cancer Center
1500 East Medical Center Drive
CCGC 6-303
Ann Arbor, MI 48109-0944

Contact Us | Maps + Directions
Patient Privacy | Privacy Statement
Price Transparency

MICHIGAN MEDICINE

UofMHealth.org
Michigan Medicine Gateway
U-M Medical School
U-M Gateway
U-M Health Blogs
Rogel INTRANET

Rogel Badge Best Hospital US News

NCCN

NCI

Notice of Nondiscrimination:

English
Deutsch
Español
Français
Italiano
Polski
Shqip
Hrvatski/Srpski
Tagalog
Tiếng Viết
Русский
العربية
فارسی
ܣܘܼܪܸܬ݂
हिंदी
বাংলা
日本語
中文
한국어

Copyright 2025 | The Regents of the University of Michigan | This site is part of Michigan Medicine. The information presented is not a tool for self diagnosis or a substitute for professional care.